Mangoceuticals, Inc. (MGRX) Financial Statements
Mangoceuticals, Inc. Financial Overview
Mangoceuticals, Inc.'s market cap is currently $5.19M. The company's EPS TTM is $-1.19; its P/E ratio is -0.20; Mangoceuticals, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 456.02K | $ 615.87K | $ 731.49K | $ 8.94K | $ 0.00 |
| Gross Profit | $ 250.39K | $ 379.96K | $ 431.50K | $ 4.85K | $ 0.00 |
| Operating Income | $ -19.15M | $ -7.97M | $ -9.22M | $ -1.99M | $ -17.52K |
| EBITDA | $ -18.82M | $ -7.96M | $ -8.09M | $ -1.99M | $ -17.52K |
| Net Income | $ -20.64M | $ -8.71M | $ -9.21M | $ -2.00M | $ -17.70K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.49M | $ 58.65K | $ 739.01K | $ 682.86K | $ 22.55K |
| Total Assets | $ 16.09M | $ 15.37M | $ 1.05M | $ 1.00M | $ 22.55K |
| Total Debt | $ 307.82K | $ 214.96K | $ 128.68K | $ 352.87K | $ 39.27K |
| Net Debt | $ -1.18M | $ 156.31K | $ -610.33K | $ -330.00K | $ 16.72K |
| Total Liabilities | $ 890.57K | $ 1.43M | $ 276.04K | $ 389.26K | $ 39.27K |
| Stockholders' Equity | $ 15.20M | $ 13.95M | $ 774.75K | $ 614.03K | $ -16.72K |
| Cash Flow | |||||
| Free Cash Flow | $ -5.85M | $ -4.86M | $ -7.00M | $ -1.39M | $ -17.52K |
| Operating Cash Flow | $ -5.85M | $ -4.86M | $ -7.00M | $ -1.35M | $ -17.52K |
| Investing Cash Flow | $ 0.00 | $ 65.00K | $ -3.52K | $ -43.10K | $ 0.00 |
| Financing Cash Flow | $ 7.27M | $ 4.13M | $ 7.06M | $ 2.05M | $ 40.07K |
Currency in USD